Sino-Singapore Knowledge City, Huangpu District, Guangzhou

Guangzhou Concord Cancer Center

广州泰和肿瘤医院

About the Hospital

GCCC offers radiotherapy, oncology, surgery, internal medicine, gynecology, nuclear medicine, anesthesiology, medical imaging, and pathology services as a "five-in-one" cancer center integrating clinical therapy, cancer prevention, clinical research, specialty training, and remote consultation. Following MD Anderson radiotherapy guidelines, NCCN clinical practice guidelines, CSCO domestic guidelines, and built to JCI standards, it provides comprehensive treatment including surgery, photon and proton radiotherapy, chemotherapy, targeted therapy, and immunotherapy, plus psychological intervention, nutritional therapy, rehabilitation, and chronic disease management. The Proton Center features four 360° rotating gantry treatment rooms with pencil-beam scanning for Intensity-Modulated Proton Therapy (IMPT) and Cone-Beam CT (CBCT) for Image-Guided Proton Therapy (IGPT). The hospital adopts a "patients-centered, doctors come to patients" model with international-standard private treatment suites. Through its telemedicine collaboration network with Mayo Clinic, patients can access comprehensive diagnostic and treatment opinions from internationally renowned experts.

Key Highlights

First Varian ProBeam 360° proton system in South China
MD Anderson Cancer Center collaboration
Mayo Clinic strategic partnership
Four 360° rotating gantry treatment rooms
IMPT with pencil-beam scanning + CBCT image guidance
Da Vinci robot, PET-MRI, PET-CT, TrueBeam accelerators
NCCN + MD Anderson radiotherapy standards + JCI
International-standard private suites + Smart Hospital

Pioneer in Proton Therapy in South China

The Proton Center at Guangzhou Concord Cancer Center houses South China's first Varian ProBeam proton radiotherapy system, marking the region's entry into the era of proton therapy for cancer treatment. The center is equipped with four 360° rotating gantry treatment rooms, utilizing advanced pencil beam scanning technology to deliver Intensity-Modulated Proton Therapy (IMPT). This technology achieves highly conformal target coverage and dose distribution, significantly reducing radiation exposure to healthy tissues and organs. The system integrates Cone-Beam Computed Tomography (CBCT) for precise patient positioning, enabling Image-guided Proton Therapy (IGPT) to further enhance accuracy and safety. The Proton Center strictly adheres to MD Anderson Cancer Center radiotherapy guidelines and standard procedures, integrating NCCN Clinical Practice Guidelines and domestic CSCO guidelines to provide scientifically grounded treatment plans. Through its telemedicine collaboration network with Mayo Clinic, patients can access comprehensive diagnostic and treatment opinions from internationally renowned experts. The core team members have extensive experience working or training at top-tier international medical institutions and have contributed to the development of domestic guidelines and medical textbooks.

World-Class Partnerships

MD Anderson Cancer Center: Ranked No.1 in the "Best Cancer Hospitals in the United States" by U.S. News & World Report for successive years. GCCC has collaborated with MD Anderson in clinical capability and quality system development, staff training, and hospital operations management. Dr. Charles M. Balch, Professor of Surgical Oncology at MD Anderson, serves as Chief Medical Consultant. Mayo Clinic: Ranked No.1 in the "Best Hospitals in the United States" by U.S. News & World Report multiple times. As a strategic partner, Mayo Clinic collaborates with GCCC across quality, diagnosis and treatment models, medical education, innovation, and patient experience to build an international cancer hospital with Chinese characteristics. From November 2019 to May 2020, Dr. Yuan Taize, Chief Physician at GCCC, completed specialized training in proton radiotherapy at Mayo Clinic.

World-Leading Medical Equipment

GCCC is equipped with cutting-edge international medical technology, enabling patients to access premier diagnostic and treatment services without going abroad: • Varian ProBeam Proton Therapy System — First in South China, 4 rotating gantry rooms, IMPT + IGPT capable • Da Vinci Surgical Robot — Precision minimally invasive surgery • PET-MRI — Next-generation molecular imaging • PET-CT — High-precision tumor metabolic imaging • TrueBeam Linear Accelerators — 4 photon treatment rooms, the world's most advanced new-generation LINAC • Digital, integrated, modular Class-100 laminar flow operating rooms

Proton Therapy Indications

The following proton therapy indications are compiled from MD Anderson Proton Therapy Center (partial list): Head & Neck Tumors: Nasopharyngeal neoplasm, oropharyngeal neoplasm, orbital tumor, skull base tumor, nasal and paranasal sinuses tumor, relapsed or newly diagnosed malignant tumor within previous radiation field Chest Tumors: Non-small cell lung cancer, esophageal carcinoma, thymoma, mesothelioma, bilateral N2 lesions after lung cancer surgery, relapsed cancer or prior chest radiation Gastrointestinal Tumors: Hepatocellular carcinoma, intrahepatic cholangiocarcinoma (ICC), solitary liver metastasis in colorectal cancer Urogenital Neoplasms: Early-stage or locally advanced prostate cancer with curative treatment indications, solitary pelvic lymph node metastasis CNS Tumors: Meningioma and sellar tumor, low-grade gliomas, primary CNS tumor requiring craniospinal irradiation Breast & Gynecological: Patients with Accelerated Partial Breast Irradiation (APBI) indications Pediatric Tumors: Astrocytoma, craniopharyngioma, ependymoma, Ewing's sarcoma, glioma, medulloblastoma, retinoblastoma, rhabdomyosarcoma, osteosarcoma, teratoma Sarcoma & Lymphoma: Mediastinal lymphoma, paraspinal lymphoma, patients requiring total brain and spinal cord irradiation

Clinical Outcomes of Proton Therapy

The following data is compiled from MD Anderson Proton Therapy Center research (partial list): • Nasopharynx Cancer: Feeding tube usage reduced by 60% • Oropharynx Cancer: Feeding tube usage reduced by 50% • Lung Cancer: Severe lung complications reduced by 57%, 3-year overall survival improved by 32% • Hepatocellular Cancer: 2-year overall survival improved by 58% • Intrahepatic Cholangiocarcinoma: 4-year overall survival improved by 54% • Chordomas: Cancer disease control improved by 49%–56% • Esophagus Cancer: Lung complications reduced by 41%, hospitalization rate reduced by 20% • Breast Cancer: Cosmetic results improved, toxicities decreased • Prostate Cancer: Severe rectal toxicities reduced by 32%–69%, moderate to big bowel problems reduced by 50%, 5-year overall survival improved by 14%–29% • Secondary Cancer Risk: Reduced by 26%–39%

International Medical Team

The medical team is led by Professor Qian Chaonan (former Vice President of Sun Yat-sen University Cancer Center), Professor Fu Shen (Chief Scientist of the National Key R&D Project on Proton and Heavy Ion Radiotherapy, former Director of Radiation Oncology at Shanghai Proton and Heavy Ion Center), and Professor Li Zuofeng (former Chief Physicist of the University of Florida Health Proton Therapy Institute). Together with a team of outstanding young and mid-career oncology experts, they provide multidisciplinary diagnosis and treatment services. Management Team: • Zhang Chengyu — Vice President of Concord Medical Group, General Manager of GCCC • Prof. Qian Chaonan — President of GCCC, former Vice President of Sun Yat-sen University Cancer Center • Prof. Fu Shen — Chief Radiotherapy Expert, Vice President of GCCC, Chief Scientist of National Key R&D Project • Prof. Li Zuofeng — Chief Physicist, former Chief Physicist of University of Florida Proton Center • Li Junwen — Vice President of GCCC • Dr. Charles M. Balch — Chief Medical Consultant, Professor of Surgical Oncology at MD Anderson, former CEO of ASCO

Patient-Centered Quality Experience

GCCC was designed by internationally renowned architecture firms HKS, Inc. and HDR International Inc., together with the Shanghai Architectural Design and Research Institute, creating a patient-centered, green, intelligent, and international cancer hospital. • "Patients-Centered, Doctors Come to Patients" Model — Developed under MD Anderson's guidance, creating a patient-centered medical process • "Mayo Service Model" — Meticulous attention to patient experience, providing high-quality one-stop full-cycle care • Smart Hospital — 5G, big data, and AI technologies integrated for appointment registration, payment, admission/discharge, and report access via mobile and computer • International-Standard Private Suites — High-quality medical services in a safe, comfortable environment with reduced cross-infection risk • Whole-Patient Care Management — Dedicated case managers provide one-on-one service throughout the entire journey • Early Diagnosis & Treatment — Preventive Medicine Center offering cancer screening, health check-ups, adult vaccination, and genetic testing

Quick Info

Sino-Singapore Knowledge City, Huangpu District, Guangzhou

SANA Partner Hospital

English & Chinese Support

Hospital TypeTertiary Oncology Hospital

Total Area100,000 sqm

Quality StandardsJCI + NCCN + MD Anderson

TelemedicineMayo Clinic direct network

24hr Hotline400-830-7338

Emailservice@ccm.cn

Inquire About This Hospital

Gallery